Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Cash from Investing Activities (2023 - 2024)

Historic Cash from Investing Activities for Coeptis Therapeutics Holdings (COEP) over the last 2 years, with Q4 2024 value amounting to $100000.0.

  • Coeptis Therapeutics Holdings' Cash from Investing Activities changed N/A to $100000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $100000.0, marking a year-over-year increase of 20000.0%. This contributed to the annual value of -$1.8 million for FY2021, which is 9768.98% up from last year.
  • Latest data reveals that Coeptis Therapeutics Holdings reported Cash from Investing Activities of $100000.0 as of Q4 2024.
  • Coeptis Therapeutics Holdings' Cash from Investing Activities' 5-year high stood at $350000.0 during Q3 2023, with a 5-year trough of -$350000.0 in Q2 2023.